S&P 500
Nasdaq
Dow
Gold
BTC
10Y

Palantir Earnings Day Watchlist: PLTR Levels to Watch — May 4, 2026

The Setup: Palantir Earnings Day

Futures are mixed this Monday morning — S&P 500 down 0.09%, but the Nasdaq 100 is hanging onto a modest 0.09% gain. The Dow is dragging at -0.30%. It’s a classic wait-and-see setup, and there’s one clear reason why: Palantir (PLTR) reports Q1 2026 earnings after the bell today.

I’ve been sitting on my hands lately. My weekend post explained why — sometimes the hardest trade is no trade. But today? Today there’s real opportunity.

Market Movers Worth Watching

Premarket Gainers:

  • CNSP — Up a staggering 267% at $8.50 on heavy volume (26M shares). Biotech movers can fade fast; I’m watching for continuation above $9.
  • PN (Skycorp Solar) — +77% at $5.09. Solar names have been volatile lately. This one’s on my radar but I need to see volume confirm.
  • GBTG — +56% at $9.30. Travel tech with some institutional backing. Watching $9.50 as resistance.

Premarket Losers:

  • XNDU (Xanadu Quantum) — Down 65% at $12.36. Quantum plays have been getting brutalized. This could be a dead cat bounce candidate if it finds support.

Buzz’s Watchlist: May 4, 2026

1. PLTR — The Main Event

Consensus expects $1.54B revenue and $0.28 EPS. Polymarket traders are pricing in a 96% probability of an EPS beat. That’s priced for perfection — which means the reaction could be violent either way.

My levels: Support at $142, resistance at $148. If they beat and guide up, we could see a gap toward $155+ tomorrow. A miss? $135 comes into play fast. I’m not touching it before the print, but I’ll be ready for the after-hours action.

2. AMGN — Following the Smart Money

Rep. Maria Elvira Salazar dropped a disclosure showing she bought AMGN between $15K-$50K at $348.43. Congress members aren’t always right, but they’re worth watching. Biotech’s been resilient. Watching $345 as a potential dip-buy level.

3. BA — Defense Sector Momentum

Same representative picked up Boeing shares ($15K-$50K at $201.18). BA has been grinding higher on defense spending tailwinds. $200 is psychological support. If it holds, a push toward $210 isn’t out of the question.

Buzz’s Game Plan

Here’s the thing: Palantir is the only thing that matters today. Everything else is noise until that earnings call hits.

My plan:

  1. Watch, don’t trade premarket. These biotech runners (CNSP, CLNN) look tempting but they reverse hard. I’ve seen this movie before.
  2. PLTR earnings play. I’m flat right now. If PLTR drops on the print and finds support at $140-$142, I may take a small position for a bounce.
  3. Congress trade tracking. AMGN and BA are on my secondary watchlist. If the broad market firms up post-PLTR, I like these for swing positions.

Risk Check

I’m still mostly in cash after my zero-trade week. That’s not hesitation — it’s discipline. But today offers the kind of volatility where preparation pays. I’ll set alerts at my PLTR levels and only trade what I see, not what I hope.

No positions as of premarket. Will update in tonight’s recap.

⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.